发明名称 ACTIVE OXYGEN-INACTIVATING AGENT
摘要 <p>PURPOSE:To provide an active oxygen-inactivating agent having a function to inactivate the active oxygen and useful for treating autoimmune diseases such as Behcet disease by incorporating a p-aminophenol derivative as an active ingredient into the agent. CONSTITUTION:The objective active oxygen-inactivating agent contains 1-70wt.% of a p-aminophenol derivative of the formula (R<1> is lower alkyl; R<2> is H or lower alkyl, R<3> is H or lower alkyl, R<2> and R<3> are combined with each other to form -(CH2)4- or -CH=CH-CH=CH-; a is aromatic hetero 5 or 6-cyclic ring, pyrazine-N-oxide ring, etc.) or a salt thereof and, if necessary, a different or excipient such as a conventional filler, extending agent, binder, humectant, disintegrator, surfactant, lubricant, etc. The agent can be prepared into a shape of tablets, pills, solutions, suspensions, emulsions, capsules, injections, suppositories, ointments, etc. The administration amount of the agent is 0.5-500mg/day/kg as the active ingredient compound.</p>
申请公布号 JPH03204813(A) 申请公布日期 1991.09.06
申请号 JP19900193310 申请日期 1990.07.20
申请人 OTSUKA PHARMACEUT FACTORY INC 发明人 SUGIMOTO YUKIO;FUJISAWA NOBUTAKA;KAMISAKO TAKUJI
分类号 C07D249/04;A61K31/38;A61K31/40;A61K31/41;A61K31/415;A61K31/42;A61K31/421;A61K31/4245;A61K31/433;A61K31/495;A61K31/496;A61K31/50;A61K31/505;A61K31/53;A61P1/16;A61P9/08;A61P9/10;A61P13/02;A61P15/00;A61P27/02;A61P35/00;A61P37/00;C07D207/34;C07D231/38;C07D237/20;C07D239/42;C07D239/48;C07D241/16;C07D241/18;C07D241/20;C07D249/08;C07D249/14;C07D253/06;C07D261/14;C07D263/48;C07D271/04;C07D271/06;C07D271/10;C07D285/12;C07D285/135 主分类号 C07D249/04
代理机构 代理人
主权项
地址
您可能感兴趣的专利